Corrigendum to Gynecological Endocrinology, 2012; 28(11): 845–849.

Corrigendum to “Inositol(s) from Bench to Bedside in Endocrinology and Gynecology”

[This corrects the article DOI: 10.1155/2017/8515703.].

Editorial: Molecular Endocrinology articles in the spotlight for November 2012.

Department of Pharmacology and Chemical Biology (D.B.D.), University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania 15260; National Institute of Diabetes and Digestive and Kidney Disease (R.M.), National Institutes of Health, Bethesda, Maryland 20892-5460; and Department of Molecular and Cellular Biology and Nuclear Receptor Signaling Atlas (N.M.), Baylor College of Medicine, Housto...

The clinical significance of anti-Müllerian hormone evaluation in gynecological endocrinology.

Anti-Müllerian hormone (AMH) is a homodimeric glycoprotein, a member of the transforming growth factor-β superfamily. Over the last decade, a large number of studies examining the multiple roles of AMH have been published. AMH levels accurately reflect the ovarian follicular reserve and could, therefore, be considered as an extremely sensitive marker of ovarian aging and a valuable tool in the ...

Anti Mullerian Hormone and its role in Gynecological Endocrinology: A Review

Anti Mullerian Hormone (AMH) is a glycoprotein belonging to the family of transforming growth factor-beta. The molecule has evolved in the last few decades for the assessment of ovarian reserve in females. Additionally this hormone has been found to be useful in predicting the success of in-vitro fertilization, marker of polycystic ovarian syndrome, granulosa cell tumor of ovary and prediction ...

Integrated Endocrinology Integrated Endocrinology